| 1.3 |
6.5 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.9 |
3.4 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.8 |
4.7 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.7 |
3.0 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.6 |
0.6 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.6 |
2.3 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.6 |
2.3 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.6 |
0.6 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.6 |
2.2 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.5 |
2.5 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.5 |
1.9 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 |
1.4 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.5 |
3.7 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.5 |
0.5 |
GO:2000532 |
renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 0.5 |
2.3 |
GO:0072313 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 |
0.5 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 0.5 |
0.5 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.5 |
1.4 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.4 |
1.3 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.4 |
3.1 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.4 |
1.3 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.4 |
1.3 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.4 |
1.6 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 |
2.0 |
GO:0003051 |
angiotensin-mediated drinking behavior(GO:0003051) |
| 0.4 |
1.6 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.4 |
1.9 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.4 |
1.5 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 |
1.4 |
GO:1905069 |
allantois development(GO:1905069) |
| 0.4 |
0.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.4 |
5.7 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 |
1.7 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 0.3 |
0.3 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.3 |
1.3 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.3 |
0.3 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.3 |
0.3 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.3 |
3.0 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 |
0.9 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.3 |
0.9 |
GO:0032900 |
negative regulation of neurotrophin production(GO:0032900) |
| 0.3 |
0.8 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.3 |
1.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 |
2.4 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.3 |
2.9 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.3 |
0.5 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.3 |
1.0 |
GO:0043324 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.3 |
0.3 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 |
0.8 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.3 |
2.8 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 |
0.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
0.8 |
GO:0032764 |
negative regulation of mast cell cytokine production(GO:0032764) |
| 0.2 |
1.5 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.2 |
1.2 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) |
| 0.2 |
1.4 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.2 |
1.0 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 |
0.2 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.2 |
1.4 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.2 |
0.9 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.2 |
0.7 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.2 |
0.5 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.2 |
4.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.2 |
0.2 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
2.7 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
0.9 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.2 |
2.0 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.2 |
1.3 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
3.9 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.2 |
3.7 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 |
1.1 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
0.6 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 |
0.6 |
GO:0043602 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.2 |
0.6 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.2 |
0.6 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 |
0.8 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.2 |
0.6 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 |
0.6 |
GO:1901253 |
negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 |
17.6 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.2 |
1.0 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.2 |
GO:0071231 |
cellular response to folic acid(GO:0071231) |
| 0.2 |
4.1 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.2 |
0.6 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.2 |
1.5 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.2 |
0.8 |
GO:0005986 |
sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) |
| 0.2 |
0.6 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 |
1.0 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 |
1.9 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.2 |
0.7 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.2 |
0.9 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.2 |
2.0 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
2.2 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.2 |
0.5 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
| 0.2 |
0.5 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 |
0.2 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.2 |
0.5 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.2 |
0.2 |
GO:0043524 |
negative regulation of neuron apoptotic process(GO:0043524) |
| 0.2 |
0.5 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
1.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
1.1 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
0.9 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.2 |
0.5 |
GO:0097254 |
renal tubular secretion(GO:0097254) |
| 0.2 |
0.2 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 |
0.9 |
GO:0097017 |
renal protein absorption(GO:0097017) |
| 0.2 |
0.3 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
| 0.2 |
1.9 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 |
0.8 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 |
0.2 |
GO:0071226 |
response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.2 |
0.3 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 |
0.2 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.2 |
0.7 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 |
1.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
2.6 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.2 |
0.5 |
GO:2000452 |
CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.2 |
1.0 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.2 |
2.3 |
GO:0019377 |
glycolipid catabolic process(GO:0019377) |
| 0.2 |
1.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 |
0.6 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 |
0.5 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.2 |
0.5 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 |
0.3 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.2 |
0.2 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.2 |
0.6 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.2 |
0.8 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.2 |
0.6 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 |
2.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.5 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.2 |
0.6 |
GO:0060844 |
arterial endothelial cell fate commitment(GO:0060844) |
| 0.2 |
0.5 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 |
0.2 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.2 |
0.5 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
1.5 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.1 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.7 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.4 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.1 |
1.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.4 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.1 |
0.4 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
0.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.6 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 0.1 |
0.6 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
3.4 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
0.1 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.4 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.1 |
1.0 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.1 |
0.3 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.1 |
0.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
0.4 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.1 |
0.1 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
0.1 |
GO:0061140 |
lung secretory cell differentiation(GO:0061140) |
| 0.1 |
1.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.4 |
GO:0051714 |
positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 |
0.5 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.1 |
0.7 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.4 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 |
0.4 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.5 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.7 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.3 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 |
1.4 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
0.5 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.1 |
0.1 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.1 |
0.1 |
GO:0009804 |
coumarin metabolic process(GO:0009804) |
| 0.1 |
0.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.6 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.1 |
0.5 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
0.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.1 |
GO:1901984 |
negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.1 |
0.5 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.1 |
0.6 |
GO:1900920 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.1 |
1.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.5 |
GO:0002290 |
gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.1 |
0.5 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.1 |
0.6 |
GO:0072233 |
thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.5 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.1 |
0.1 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.1 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 |
0.8 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.1 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.7 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
0.7 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.5 |
GO:0002740 |
negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 0.1 |
0.5 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
0.2 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.1 |
0.4 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
0.4 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.3 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.1 |
0.6 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.1 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.1 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 |
0.3 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.1 |
0.2 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 |
0.8 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.2 |
GO:0034627 |
'de novo' NAD biosynthetic process(GO:0034627) |
| 0.1 |
0.3 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 0.1 |
0.7 |
GO:0071503 |
response to heparin(GO:0071503) |
| 0.1 |
0.3 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 |
0.3 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.1 |
0.3 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
2.6 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
0.2 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.1 |
GO:1902622 |
regulation of neutrophil migration(GO:1902622) |
| 0.1 |
0.5 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.1 |
0.9 |
GO:0060737 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.1 |
1.5 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.7 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.4 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 |
1.7 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.6 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
1.9 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.5 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.1 |
1.0 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.3 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.1 |
0.4 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.1 |
0.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
0.3 |
GO:0002752 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.1 |
0.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
4.4 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 |
0.3 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 |
0.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.3 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.2 |
GO:0014806 |
smooth muscle hyperplasia(GO:0014806) |
| 0.1 |
0.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.3 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 |
0.1 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.4 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 |
0.4 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.7 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.1 |
0.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.4 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.1 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.1 |
0.4 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.9 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.1 |
GO:1900111 |
regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 |
0.1 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
1.2 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
0.4 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.2 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.5 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
1.7 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.1 |
GO:0021626 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.1 |
0.8 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.3 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 |
0.3 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.1 |
0.2 |
GO:2000296 |
negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.1 |
0.4 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.5 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.1 |
0.1 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
0.6 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.3 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 |
0.4 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
5.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.2 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.1 |
0.7 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.5 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 |
0.6 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
1.5 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 |
0.2 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.1 |
1.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.2 |
GO:2000566 |
positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
| 0.1 |
0.3 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.4 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.1 |
1.6 |
GO:0032196 |
transposition(GO:0032196) |
| 0.1 |
0.2 |
GO:0071560 |
cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.1 |
2.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.5 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.1 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.8 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.3 |
GO:1903061 |
positive regulation of protein lipidation(GO:1903061) |
| 0.1 |
0.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 |
0.1 |
GO:0010463 |
mesenchymal cell proliferation(GO:0010463) |
| 0.1 |
0.3 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.5 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
0.8 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
0.3 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
0.3 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.1 |
0.1 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.1 |
0.2 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.1 |
0.3 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.4 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.6 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.2 |
GO:0055073 |
cadmium ion homeostasis(GO:0055073) |
| 0.1 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 |
0.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
1.0 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
1.4 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.2 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.2 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.1 |
0.8 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.1 |
0.9 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.4 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.3 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.3 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 |
0.1 |
GO:1903802 |
L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 0.1 |
0.8 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
6.0 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.5 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.2 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
0.3 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.1 |
0.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.5 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.1 |
0.2 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 |
2.2 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.1 |
0.2 |
GO:0061082 |
myeloid leukocyte cytokine production(GO:0061082) |
| 0.1 |
0.2 |
GO:2000870 |
regulation of progesterone secretion(GO:2000870) |
| 0.1 |
0.2 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.1 |
0.5 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.1 |
0.2 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.1 |
0.2 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
0.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.3 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.1 |
0.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.1 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.6 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 |
0.2 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.1 |
0.2 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.7 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.4 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.3 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 |
0.1 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.1 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
5.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.1 |
GO:2001183 |
negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.1 |
2.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.6 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.4 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.1 |
0.2 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.1 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 |
0.5 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
0.2 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.1 |
0.4 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.3 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.1 |
0.2 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
0.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.2 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.2 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.0 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.3 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.3 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
1.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.6 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.4 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.2 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 |
1.4 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.2 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 |
1.3 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.3 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.1 |
0.5 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.1 |
GO:0014721 |
voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
| 0.1 |
0.1 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
1.3 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
1.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.3 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 |
1.6 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
1.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.7 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.4 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.3 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.3 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
0.2 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.2 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 |
0.6 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.8 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.1 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.3 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.6 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.3 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 |
0.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.4 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.2 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.2 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 |
0.1 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.3 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
1.3 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.2 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.1 |
0.4 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.1 |
0.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.1 |
0.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.2 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
1.0 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.2 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.1 |
GO:1903514 |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) endoplasmic reticulum to cytosol transport(GO:1903513) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
| 0.1 |
0.2 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.2 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.1 |
0.3 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.1 |
0.1 |
GO:0032881 |
regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
| 0.1 |
0.8 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.1 |
GO:0097325 |
melanocyte proliferation(GO:0097325) |
| 0.1 |
0.3 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 |
0.7 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.2 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 |
0.2 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.1 |
0.1 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 |
0.2 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.1 |
0.1 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.1 |
0.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.8 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.1 |
GO:0060974 |
cell migration involved in heart formation(GO:0060974) |
| 0.1 |
0.2 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.1 |
1.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.6 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.1 |
GO:0045714 |
regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 |
0.1 |
GO:0071655 |
granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) |
| 0.1 |
0.2 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.1 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.1 |
0.2 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 |
0.1 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.1 |
0.5 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.1 |
0.2 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.1 |
0.1 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
2.1 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.1 |
0.6 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.1 |
0.2 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 |
0.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.3 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
0.2 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.1 |
0.3 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
0.3 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.1 |
0.2 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.1 |
0.5 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.1 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 |
0.3 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
1.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.3 |
GO:0072378 |
blood coagulation, intrinsic pathway(GO:0007597) blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 |
0.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.6 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.3 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 |
0.7 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.1 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
0.1 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.1 |
0.1 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
1.1 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.2 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 |
0.3 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
0.1 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
1.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.1 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.1 |
0.4 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.7 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
0.1 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.1 |
0.1 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 |
0.4 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.2 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
1.1 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.2 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 |
0.1 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.1 |
5.2 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.2 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 |
0.5 |
GO:0099638 |
endosome to plasma membrane protein transport(GO:0099638) |
| 0.1 |
0.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.1 |
1.7 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 |
0.2 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.4 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.8 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.1 |
0.6 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.1 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 |
0.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.2 |
GO:2000563 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 |
0.5 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.2 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.1 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.2 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.1 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.1 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 |
0.8 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
0.3 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
0.3 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.1 |
0.2 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.7 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.7 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
0.2 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.3 |
GO:0070071 |
proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.1 |
0.2 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.0 |
0.2 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.1 |
GO:0042704 |
uterine wall breakdown(GO:0042704) |
| 0.0 |
0.3 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.0 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 |
0.6 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
1.0 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.1 |
GO:0036017 |
response to erythropoietin(GO:0036017) |
| 0.0 |
0.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.1 |
GO:0010841 |
positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 0.0 |
0.1 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.0 |
0.1 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.0 |
0.1 |
GO:0046886 |
positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
1.4 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
1.1 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.0 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.0 |
1.0 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.5 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 |
1.2 |
GO:0036508 |
protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.0 |
0.4 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.0 |
0.1 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.0 |
0.2 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.5 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.4 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.1 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.3 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.3 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.3 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.0 |
0.2 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.0 |
0.1 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.0 |
0.2 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.5 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
1.1 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.4 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.2 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.0 |
0.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.2 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 |
0.1 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 |
0.5 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.5 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.0 |
0.2 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.6 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
1.0 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.0 |
GO:1901018 |
positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
| 0.0 |
0.3 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 |
0.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.3 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
1.0 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.1 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
0.1 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.0 |
0.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.0 |
0.1 |
GO:0061188 |
negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.2 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 |
0.2 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.0 |
1.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.0 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.0 |
0.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.7 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.0 |
0.4 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.2 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 |
0.4 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.0 |
0.1 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.0 |
0.2 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.0 |
0.0 |
GO:0043506 |
regulation of JUN kinase activity(GO:0043506) |
| 0.0 |
0.2 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.5 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.3 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.1 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.2 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.2 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.0 |
1.1 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.0 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.0 |
0.1 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.0 |
0.2 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.3 |
GO:0002070 |
epithelial cell maturation(GO:0002070) |
| 0.0 |
0.1 |
GO:2000439 |
positive regulation of monocyte extravasation(GO:2000439) |
| 0.0 |
0.0 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.2 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.0 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
2.4 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.2 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.1 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.0 |
0.6 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.0 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.3 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.3 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.4 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
0.1 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 |
0.0 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.2 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.1 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.0 |
1.9 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.0 |
0.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.2 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.0 |
0.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.2 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.1 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.0 |
1.1 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.2 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.5 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.2 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.0 |
1.9 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.7 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.0 |
0.2 |
GO:0043415 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.0 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.2 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.3 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.0 |
0.2 |
GO:0010524 |
positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.0 |
0.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.2 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.3 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.6 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.3 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.1 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.0 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.4 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.7 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.0 |
0.1 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.0 |
0.0 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.0 |
1.0 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.2 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 |
0.7 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.4 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.4 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.1 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.0 |
0.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.1 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.0 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.0 |
0.5 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.0 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 |
0.0 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.0 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
0.2 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.1 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.0 |
0.2 |
GO:2000553 |
positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.0 |
0.2 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 |
0.1 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.0 |
1.3 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 |
0.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.0 |
0.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.0 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
1.2 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.4 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.1 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.0 |
0.3 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
1.8 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 |
0.2 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.0 |
GO:0055069 |
zinc ion homeostasis(GO:0055069) |
| 0.0 |
0.1 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.6 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.0 |
0.2 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.1 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.2 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.1 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.0 |
0.5 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.3 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.0 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 |
1.0 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.2 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.5 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.6 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.0 |
0.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
0.6 |
GO:0015669 |
gas transport(GO:0015669) |
| 0.0 |
0.1 |
GO:0009730 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 |
0.2 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.0 |
0.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.3 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.2 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 |
0.1 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.0 |
1.1 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.5 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.3 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.0 |
0.6 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.4 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.1 |
GO:0003160 |
endocardium morphogenesis(GO:0003160) |
| 0.0 |
0.8 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.0 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.1 |
GO:0044026 |
DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
| 0.0 |
0.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.1 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.0 |
1.4 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.2 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.0 |
0.1 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.0 |
0.1 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.0 |
0.1 |
GO:0022009 |
establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
| 0.0 |
0.2 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.0 |
0.1 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.0 |
0.1 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.3 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.0 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.1 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.0 |
0.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.0 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 0.0 |
0.2 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.0 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 |
0.3 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.2 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.0 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.0 |
0.3 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.0 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.0 |
0.3 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.2 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.0 |
0.1 |
GO:0072112 |
renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.0 |
0.3 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 |
0.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
1.2 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.0 |
0.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.0 |
0.3 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.1 |
GO:0051709 |
regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
| 0.0 |
0.2 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.0 |
0.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.0 |
3.1 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.3 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
1.4 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 |
0.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.2 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 |
0.0 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.0 |
0.4 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.1 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 |
0.6 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.1 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 |
0.1 |
GO:0060996 |
dendritic spine development(GO:0060996) |
| 0.0 |
0.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 |
0.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.2 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.0 |
0.1 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.0 |
0.1 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 |
0.1 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.2 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.3 |
GO:0015874 |
norepinephrine transport(GO:0015874) |
| 0.0 |
0.0 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.1 |
GO:0007402 |
ganglion mother cell fate determination(GO:0007402) |
| 0.0 |
0.1 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.0 |
0.1 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.0 |
0.2 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.4 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.2 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.3 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
0.3 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.3 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.0 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.2 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.0 |
0.1 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.0 |
0.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.0 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.0 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.0 |
0.1 |
GO:0007033 |
vacuole organization(GO:0007033) |
| 0.0 |
0.0 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.4 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.0 |
0.1 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.0 |
0.0 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.3 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.0 |
0.5 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.1 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
0.6 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.3 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 |
0.0 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 |
0.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.1 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.0 |
0.4 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.0 |
0.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.0 |
0.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 |
0.4 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.1 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 |
0.3 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.0 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.1 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.0 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.1 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.0 |
0.0 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.0 |
0.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.1 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.3 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.6 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.0 |
0.1 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.1 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.0 |
GO:0045799 |
positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.0 |
0.1 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
3.2 |
GO:0002790 |
peptide secretion(GO:0002790) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.2 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.0 |
0.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.2 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
0.4 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 |
0.0 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.0 |
0.1 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.1 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.0 |
0.0 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.0 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.0 |
0.1 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.0 |
0.1 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 |
0.0 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.1 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.0 |
0.3 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.0 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.0 |
0.2 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.2 |
GO:0048858 |
cell projection morphogenesis(GO:0048858) |
| 0.0 |
0.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.0 |
0.1 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.0 |
0.0 |
GO:0046514 |
ceramide catabolic process(GO:0046514) |
| 0.0 |
0.1 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.0 |
0.0 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.2 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.0 |
0.0 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0010677 |
negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
| 0.0 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.9 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 |
0.0 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.0 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
0.1 |
GO:0009261 |
purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
| 0.0 |
0.1 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.0 |
0.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.0 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
0.1 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.0 |
0.2 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.1 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.6 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
0.3 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.1 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.0 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.1 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.0 |
0.1 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.7 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.2 |
GO:0048863 |
stem cell differentiation(GO:0048863) |
| 0.0 |
0.0 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.0 |
0.1 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.1 |
GO:0002562 |
somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
| 0.0 |
0.2 |
GO:0060711 |
labyrinthine layer development(GO:0060711) |
| 0.0 |
0.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.0 |
GO:0060492 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.0 |
0.2 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.3 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.0 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.0 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
0.0 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.0 |
0.1 |
GO:0048263 |
determination of dorsal identity(GO:0048263) |
| 0.0 |
0.1 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 |
0.0 |
GO:0036296 |
response to increased oxygen levels(GO:0036296) |
| 0.0 |
0.1 |
GO:1901624 |
negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.0 |
0.3 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 |
0.2 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.2 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.0 |
GO:1902932 |
positive regulation of alcohol biosynthetic process(GO:1902932) |
| 0.0 |
0.0 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.0 |
0.4 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.0 |
GO:0010934 |
macrophage cytokine production(GO:0010934) |
| 0.0 |
0.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.0 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.0 |
0.3 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.0 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.0 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.0 |
0.2 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 |
0.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.3 |
GO:2001046 |
positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 |
0.0 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.0 |
0.2 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.0 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.0 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.0 |
0.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 |
0.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.0 |
0.1 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.0 |
0.0 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.0 |
0.1 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.0 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.0 |
0.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.3 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.0 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.0 |
0.0 |
GO:0034128 |
regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.0 |
0.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.0 |
0.0 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.0 |
0.1 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.0 |
GO:0045990 |
carbon catabolite regulation of transcription(GO:0045990) |
| 0.0 |
0.2 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.0 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.0 |
0.0 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.1 |
GO:0001905 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
| 0.0 |
0.1 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.0 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.0 |
0.0 |
GO:1903527 |
regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0071354 |
cellular response to interleukin-6(GO:0071354) |
| 0.0 |
0.0 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.0 |
0.1 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
| 0.0 |
0.0 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.0 |
0.0 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.0 |
0.1 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.0 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.1 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.1 |
GO:0032799 |
low-density lipoprotein receptor particle metabolic process(GO:0032799) low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 |
0.0 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.1 |
GO:0032094 |
response to food(GO:0032094) |
| 0.0 |
0.0 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.0 |
0.1 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.0 |
0.0 |
GO:1903798 |
regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
1.5 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.1 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.0 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.1 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.1 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.0 |
0.0 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.0 |
0.0 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.2 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.0 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.1 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.0 |
0.3 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.0 |
GO:0010816 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.0 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.0 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.0 |
0.1 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.0 |
0.0 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.0 |
GO:0003157 |
endocardium development(GO:0003157) |
| 0.0 |
0.1 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 |
0.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.1 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 |
0.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.0 |
GO:0071362 |
cellular response to ether(GO:0071362) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.0 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.0 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.0 |
0.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.1 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.1 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.0 |
0.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.3 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.0 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.9 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.0 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.0 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.0 |
0.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.1 |
GO:0016064 |
immunoglobulin mediated immune response(GO:0016064) B cell mediated immunity(GO:0019724) |
| 0.0 |
0.0 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.0 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.3 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 |
0.0 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.1 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.0 |
GO:0002724 |
regulation of T cell cytokine production(GO:0002724) |
| 0.0 |
0.0 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 |
1.5 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.1 |
GO:0010827 |
regulation of glucose transport(GO:0010827) |
| 0.0 |
0.0 |
GO:0003339 |
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
| 0.0 |
0.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 |
0.1 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.2 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.0 |
0.1 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.0 |
0.0 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.1 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.0 |
0.1 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.1 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.0 |
0.3 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.7 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.1 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.0 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.7 |
GO:0046330 |
positive regulation of JNK cascade(GO:0046330) |
| 0.0 |
0.0 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
